Potential predictive factors of osteoporosis in HIV-positive subjects.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Bone

• Publication date

  2006-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.BONE.2005.11.001PMID 16377270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radiology of Osteoporosis

  2008cited by this paper
• Guidelines for diagnosis and management of osteoporosis

  2005cited by this paper
• The effects of standardization and reference values on patient classification for spine and femur dual-energy X-ray absorptiometry

  2005cited by this paper
• Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.

  2004cited by this paper
• Emerging bone problems in patients infected with human immunodeficiency virus.

  2003cited by this paper
• Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy

  2003cited by this paper
• BMD Is Reduced in HIV‐Infected Men Irrespective of Treatment

  2003cited by this paper
• Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women

  2003cited by this paper
• Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.

  2003cited by this paper
• HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D

  2003cited by this paper
• Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.

  2001cited by this paper
• Osteopenia in HIV-infected patients: is it the disease or is it the treatment?

  2001cited by this paper
• Possible Fatal Interaction between Protease Inhibitors and Methamphetamine

  2000cited by this paper
• Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

  2000influential reference
• Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four Cases

  2000cited by this paper
• Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

  1999cited by this paper
• Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

  1998cited by this paper
• A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Visceral abdominal-fat accumulation associated with use of indinavir.

  1998cited by this paper
• Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis

  1997cited by this paper
• NF-kappaB and bone: the breaking point.

  1997cited by this paper
• Decline in deaths from AIDS due to new antiretrovirals.

  1997cited by this paper
• Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.

  1997cited by this paper
• NF-κB and bone: The breaking point

  1997cited by this paper
• Changes in quantitative bone histomorphometry in aging healthy men.

  1996cited by this paper
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

  1994cited by this paper
• Bone gain in young adult women.

  1992cited by this paper
• Perspective how many women have osteoporosis?

  1992cited by this paper
• Bone histomorphometric reference values in 88 normal Italian subjects.

  1990cited by this paper

• Impact of biomechanical loading on bone mineral density explored in weight-bearing and non-weight- bearing bones of people living with HIV: An observational study

  2023cites this paper
• The role of TEMRA cell-mediated immune senescence in the development and treatment of HIV disease

  2023cites this paper
• Impact of weight-bearing and sex-stratified differences in risk factors of bone loss on bone mineral density in HIV conditions – findings of the Nigeria HIV-BMD study: An observational study

  2022cites this paper
• HIV, pathology and epigenetic age acceleration in different human tissues

  2022cites this paper
• DNA Methylation and Immune Cell Markers Demonstrate Evidence of Accelerated Aging in Patients with Chronic Hepatitis B Virus or Hepatitis C Virus, with or without Human Immunodeficienct Virus Co-infection

  2021cites this paper
• Low bone mass in people living with HIV on long-term anti-retroviral therapy: A single center study in Uganda

  2021cites this paper
• HIV and Osteoporosis

  2020cites this paper
• Association of Low Vitamin D Status with Complications of HIV and AIDS: A Literature Review.

  2020cites this paper
• Male Osteoporosis: Gender Differences in Pathophysiology, Clinical Aspects, Diagnosis and Treatment

  2020cites this paper
• DNA Methylation and Immune Cell Markers Demonstrate Evidence of Accelerated Aging in Patients with Chronic HBV or HCV, with or without HIV Co-Infection.

  2020cites this paper
• Chronic kidney disease is related to femoral neck bone loss among HIV-1-infected patients : a retrospective study

  2019cites this paper
• Implications of Immune Checkpoint Expression During Aging in HIV-Infected People on Antiretroviral Therapy

  2019cites this paper
• Alendronate/Vitamin D for attenuating bone mineral density loss during antiretroviral initiation: a pilot randomized controlled trial.

  2019cites this paper
• Fracture Risk Assessment in People Living with HIV Infection

  2019influential citation
• Déterminants du vieillissement dans l'infection par le VIH : étude SIMBAD

  2019cites this paper
• Ageing with HIV

  2018cites this paper
• ОБОСНОВАНИЕ ИССЛЕДОВАНИЯ ПО ОПТИМИЗАЦИИ СИСТЕМЫ ОКАЗАНИЯ ХИРУРГИЧЕСКОЙ СТОМАТОЛОГИЧЕСКОЙ ПОМОЩИ ПАЦИЕНТАМ С ВИЧ-ИНФЕКЦИЕЙ. АНАЛИТИЧЕСКИЙ ОБЗОР ЛИТЕРАТУРЫ

  2018cites this paper
• Bone mineral status and renal tubular dysfunction in HIV-positive men

  2018influential citation
• JUSTIFICATION OF RESEARCH ON SYSTEM OPTIMIZATION OF SURGICAL DENTAL CARE TO PATIENTS WITH HIV INFECTION. ANALYTICAL REVIEW OF LITERATURE

  2018cites this paper
• HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation

  2017cites this paper
• TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study

  2017cites this paper
• Global Virology II - HIV and NeuroAIDS

  2017cites this paper
• Full title : Reduced bone mineral density in HIV-infected patients : prevalence and associated factors , ANRS CO 3 Aquitaine cohort Short title : Reduced bone mineral density in HIV patients

  2017cites this paper
• Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.

  2017cites this paper
• Emphysema is associated with thoracic vertebral bone attenuation on chest CT scan in HIV-infected individuals

  2017cites this paper
• Body composition in HIV-infected patients receiving highly active antiretroviral therapy

  2017cites this paper
• Diagnosis of Bone Changes in Mandibles of Aids Patients Who Had Administered Haart and Developed Lipodistrophic Syndrome

  2017cites this paper
• Genetic, Epigenetic, and Transcriptomic Studies of NeuroAIDS

  2017cites this paper
• Alveolar bone in human immunodeficiency virus infection: is it changed by long-term antiretroviral therapy?

  2017cites this paper
• Protecting bone in long-term HIV positive patients receiving antiretrovirals

  2016influential citation
• Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21

  2016cites this paper
• Systemic inflammatory response and mortality in hospitalized elderly patients

  2016cites this paper
• The silent war of CMV in aging and HIV infection.

  2016cites this paper
• Decreased serum bone specific alkaline phosphatase and increased urinary N-terminal telopeptide of type I collagen as prognostic markers for bone mineral density loss in HIV patients on cART.

  2016cites this paper
• Serum Sclerostin Levels in Patients with Human Immunodeficiency Virus Infection and Their Association with Bone Turnover Markers and Bone Mineral Densitometry

  2016cites this paper
• AN OVERVIEW OF BONE DISEASE IN HIV-INFECTED PATIENTS

  2015cites this paper
• Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders

  2015cites this paper
• Chest Low-Dose Computed Tomography for Early Lung Cancer Diagnosis as an Opportunity to Diagnose Vertebral Fractures in HIV-Infected Smokers, an ANRS EP48 HIV CHEST Substudy

  2015cites this paper
• HIV-1 Infection Accelerates Age According to the Epigenetic Clock

  2015cites this paper
• Acceleration of Age-Associated Methylation Patterns in HIV-1-Infected Adults

  2015cites this paper
• Prevalence of Osteoporosis among HIV-1-Infected Men and Women Aged 50 years and Older in Dakar, Senegal: A Cross-Sectional Study

  2015cites this paper
• Association of Blood Biomarkers of Bone Turnover in HIV-1 Infected Individuals Receiving Anti-Retroviral Therapy (ART).

  2014cites this paper
• "FACTORES ASOCIADOS A OSTEOPOROSIS Y OSTEOPENIA EN PACIENTES CON INFECCIÓN POR VIH EN LA UNIDAD DE ATENCIÓN INTEGRAL DE PVV DEL HOSPITAL ENRIQUE GARCÉS QUITO- ECUADOR DURANTE EL PERIODO DE ENERO DE 2013 A JUNIO DE 2013".

  2014cites this paper
• The Effect of HIV-Hepatitis C Co-Infection on Bone Mineral Density and Fracture: A Meta-Analysis

  2014influential citation
• Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis

  2014cites this paper
• Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection

  2014cites this paper
• The effects of untreated and treated HIV infection on bone disease

  2014cites this paper
• Chronic Viral Hepatitis Is Associated With Low Bone Mineral Density in HIV-Infected Patients, ANRS CO 3 Aquitaine Cohort

  2013cites this paper
• Vitamin D status in young HIV infected women of various ethnic origins: incidence of vitamin D deficiency and possible impact on bone density.

  2013cites this paper
• Bone Mineral Density Effects of Randomized Regimen and Nucleoside Reverse Transcriptase Inhibitor Selection from ACTG A5142

  2013cites this paper
• Treatment of primary HIV infection

  2013cites this paper
• Bone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy –a prospective observational study

  2013cites this paper
• Evaluation of bone alterations in the jaws of HIV-infected menopausal women.

  2013cites this paper
• Phalangeal quantitative ultrasound: cheaper methods for screening and follow-up of bone pathologies in HIV-infected women?

  2013influential citation
• The content of manganese and iron in hip joint tissue.

  2013cites this paper
• Factors influencing bone mineral density in ARV-naive patients at Sanglah Hospital, Bali.

  2013cites this paper
• Bone Effects of Rosiglitazone in HIV-Infected Patients With Lipoatrophy

  2012cites this paper
• Care of the human immunodeficiency virus-infected menopausal woman.

  2012cites this paper
• Reduced Quantitative Ultrasound Bone Mineral Density in HIV-Infected Patients on Antiretroviral Therapy in Senegal

  2012cites this paper
• The Effect of Tenofovir on Vitamin D Metabolism in HIV-Infected Adults Is Dependent on Sex and Ethnicity

  2012cites this paper
• Osteopenia and osteoporosis among patients with human immunodeficiency virus infection

  2012cites this paper
• Recognizing and treating secondary osteoporosis

  2012cites this paper
• Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

  2012cites this paper
• Therapeutic Options for Low Bone Mineral Density in HIV-Infected Subjects

  2012cites this paper
• The Role of Vitamin D Deficiency in the Pathogenesis of Osteoporosis and in the Modulation of the Immune System in HIV-Infected Patients

  2012cites this paper
• Osteoporosis and Bone Health in HIV

  2012cites this paper
• Use of Dual-Energy X-Ray Absorptiometry (DXA) Scans in HIV-Infected Patients

  2012cites this paper
• Bone disease in HIV infection.

  2011cites this paper
• Prevention of bone loss and management of fracture risk in HIV-infected individuals: case studies and recommendations for different patient subgroups

  2011cites this paper
• Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity.

  2011cites this paper
• Bone turnover markers in HIV disease.

  2011cites this paper
• The dual of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment.

  2011cites this paper
• Low CD4 Count Is Associated With an Increased Risk of Fragility Fracture in HIV-Infected Patients

  2011cites this paper
• Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population.

  2011cites this paper
• Prospective one-year bone loss in treatment-naïve HIV+ men and women on single or multiple drug HIV therapies.

  2011cites this paper
• HIV infection and bone disease: implications for an aging population.

  2011cites this paper
• The Dual Impact of HIV-1 Infection and Aging on Naïve CD4+ T-Cells: Additive and Distinct Patterns of Impairment

  2011cites this paper
• Risk factors of osteopenia in HIV-infected women: no role of antiretroviral therapy.

  2010cites this paper
• Bone mineral density in HIV-infected women taking antiretroviral therapy: a systematic review.

  2010cites this paper
• HIV and bone mineral density

  2010cites this paper
• HIV and bone disease.

  2010cites this paper
• Aging and HIV Infection: A Comparison Between Older HIV-Infected Persons and the General Population

  2010cites this paper
• High prevalence of reduced bone mineral density in primary HIV-1-infected men

  2010cites this paper
• A challenge for the future: aging and HIV infection

  2010cites this paper
• Pathogenesis of bone disorders in HIV infection

  2009cites this paper
• Estratègies de simplificació del tractament antiretroviral en diferents estadiatges de la infecció pel VIH-1

  2009cites this paper
• Continuous antiretroviral therapy decreases bone mineral density

  2009cites this paper
• Human Immunodeficiency Virus and Highly Active Antiretroviral Therapy–Associated Metabolic Disorders and Risk Factors for Cardiovascular Disease

  2009cites this paper
• Tenofovir y enfermedad sea en pacientes infectados por el VIH

  2009cites this paper
• Vertebral fractures in AIDS patients within 6 months from highly active antiretroviral therapy initiation: two case reports.

  2008cites this paper
• [Bone mineral loss in patients with human immunodeficiency virus infection].

  2008cites this paper
• Reduced bone mineral density in HIV-infected patients: prevalence and associated factors

  2008cites this paper
• HIV‐1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFα activation

  2008cites this paper
• Gynecologic Issues in the

  2008cites this paper
• Adverse Effects of Drugs on Bone and Calcium Metabolism/Physiology

  2008cites this paper
• Disminución de la masa ósea en pacientes con infección por el virus de la inmunodeficiencia humana

  2008cites this paper
• Risk factors for decreased bone density and effects of HIV on bone in the elderly

  2008cites this paper
• Bone alterations during HIV infection.

  2008cites this paper
• Disminución de la masa ósea en pacientes con infección por el virus de la inmunodeficiencia humana

  2008cites this paper
• Gynecologic issues in the HIV-infected woman.

  2008cites this paper